Recombinant protein growth factor
This page covers all Recombinant protein growth factor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting BMP-2 receptor (ALK2/ALK3).
Targets
Phase 3 pipeline (1)
- Novosis(bongros/BMP-2) · Daewoong Pharmaceutical Co. LTD. · Orthopedics / Bone regeneration
Novosis is a recombinant human bone morphogenetic protein-2 (BMP-2) that promotes bone formation by stimulating osteoblast differentiation and new bone growth.
Patent intelligence
- recombinant protein growth factor patent landscape — aggregated cliff calendar, attackable patents, originator estates